VALHALLA

Fujifilm Announces Availability of FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens: Wide, Light, and Long

Retrieved on: 
Thursday, March 7, 2024
NAB Show, Lens, Fujifilm, Fujinon, Steadicam, NAB, Telescopic sight

VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).

Key Points: 
  • VALHALLA, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation’s Optical Devices Division announces the availability of its new FUJINON Duvo™ HZK24-300mm Portable PL Mount Zoom Lens (”Duvo 24-300mm“).
  • Fujifilm expects to begin shipping initial orders of Duvo 24-300mm to customers at the end of March, 2024.
  • This versatile portable lens can be used with a tripod, shoulder-mounted with a Steadicam [2] , or for high-angle shooting, using a crane.
  • Complementing the previously released FUJINON Duvo™ HZK25-1000mm F2.8-F5.0 PL Mount Cinema Box Lens (“Duvo 25-1000mm”) — Fujifilm’s first Duvo Series lens — Duvo 24-300mm delivers 12.5x zoom, covering the frequently used 24-300mm focal range.

Fujifilm Receives 510(k) Clearance for SCALE EYE®, a Novel Endoscopic Imaging Technology for Measuring Colonic Lesions

Retrieved on: 
Monday, February 26, 2024
Polyp (medicine), Colonoscopy, FDA, Polyp, EYE, Risk, Fujifilm, Colorectal polyp, PMID, Malignancy, Instrument, Subjectivity, NYU Langone Health, SCALE, Neoplasm, Hepatology

LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, has been granted FDA 510(k) clearance for SCALE EYE, a new endoscopic imaging technology and part of its expanding ELUXEO Endoscopic Imaging System.

Key Points: 
  • LEXINGTON, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of endoscopic imaging and endosurgical solutions, has been granted FDA 510(k) clearance for SCALE EYE, a new endoscopic imaging technology and part of its expanding ELUXEO Endoscopic Imaging System.
  • Measurement time was 2.8 seconds using SCALE EYE, compared to 8 seconds when measuring with forceps.
  • Comparing size measurement of colorectal polyps using a novel virtual scale endoscope, endoscopic ruler or forceps: A preclinical randomized trial.
  • Introduction and preliminary evaluation of novel endoscope with pinpoint laser technology for adequate size estimation of colon lesions.

Fujifilm Receives PACS Award for Naval Medical Center - San Diego

Retrieved on: 
Tuesday, February 20, 2024
Enterprise imaging, DOD, Cardiology, 3D, Radiology, Authority, Health, Fujifilm, Mammography, Organization, RMF, Risk Management Framework, PACS, Synapse, Medical imaging

Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.

Key Points: 
  • Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation , a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.
  • Synapse 7x unites data and imaging from radiology, mammography, cardiology, 3D and other enterprise imaging solutions on server-side rendering technology.
  • With Synapse 7x, organizations within the DoD network – now including Naval Medical Center - San Diego - will be able to access the diagnostic PACS platform that extends across the enterprise, an evolution from a radiology-specific PACS platform.
  • This award includes Navy Medical Center San Diego, Camp Pendleton, 29 Palms, Lemoore, plus approximately 40 additional medical treatment facilities will consolidate PACS vendors to have Fujifilm become the sole provider, streamlining patient imaging and data across the entire network.

Fujifilm Debuts X100VI Mirrorless Digital Camera

Retrieved on: 
Tuesday, February 20, 2024
Cloud, ISO, GFX100, Bird, USD, Weather, Aluminium, Camera, Animal, EVF, Motorcycle, Photography, IBIS, Limited Edition, Series, OLED, ERF, MSRP, Silver, LCD, OVF, TCL

VALHALLA, N.Y., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation is pleased to officially announce the highly anticipated launch of FUJIFILM X100VI digital camera ("X100VI", pronounced X100 Six), the newest model in the popular X100 Series.

Key Points: 
  • VALHALLA, N.Y., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation is pleased to officially announce the highly anticipated launch of FUJIFILM X100VI digital camera ("X100VI", pronounced X100 Six), the newest model in the popular X100 Series.
  • X100VI is the latest in Fujifilm‘s digital camera portfolio to integrate Frame.io’s Camera to Cloud technology, joining X-H2, X-H2S, and GFX100 II in offering the capability.
  • These numbered X100VI units are packaged in a special, soft-release box that includes a special strap and Fujifilm history cards.
  • X100VI is expected to be available from Fujifilm dealers early March 2024 at a Manufacturer’s Suggested Retail Price of $1,599.95 USD and $2,159.99 CAD.

Fujifilm Receives PACS Award for Naval Medical Center - San Diego

Retrieved on: 
Tuesday, February 20, 2024
Enterprise imaging, DOD, Cardiology, 3D, Radiology, Authority, Health, Fujifilm, Mammography, Organization, RMF, Risk Management Framework, PACS, Synapse, Medical imaging

Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.

Key Points: 
  • Lexington, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced that the company was selected to transform the enterprise radiology PACS at the Naval Medical Center - San Diego with Synapse® 7x – Fujifilm’s next-generation enterprise imaging platform.
  • Synapse 7x unites data and imaging from radiology, mammography, cardiology, 3D and other enterprise imaging solutions on server-side rendering technology.
  • With Synapse 7x, organizations within the DoD network – now including Naval Medical Center - San Diego - will be able to access the diagnostic PACS platform that extends across the enterprise, an evolution from a radiology-specific PACS platform.
  • This award includes Navy Medical Center San Diego, Camp Pembleton, 29 Palms, Lemoore, plus approximately 40 additional medical treatment facilities will consolidate PACS vendors to have Fujifilm become the sole provider, streamlining patient imaging and data across the entire network.

Fujifilm Celebrates Recent Recipients of Fujifilm Fellowships at Harvard Medical School

Retrieved on: 
Tuesday, February 20, 2024
Lilium, Therapy, Research, Doctor of Philosophy, Drug resistance, Chemical biology, G protein-coupled receptor, Biology, Obesity, Pain, MIT, Harvard University, Drug discovery, Eurosport 1, Health, Fujifilm, Faculty (division), Disease, Massachusetts General Hospital, Harvard Medical School, Infection, Publication, Faculty, Fujifilm Diosynth Biotechnologies, Management

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Holdings America Corporation (Fujifilm), today announced the nine most recent Fujifilm Fellows at Harvard Medical School.

Key Points: 
  • CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Holdings America Corporation (Fujifilm), today announced the nine most recent Fujifilm Fellows at Harvard Medical School.
  • These PhD students from around the world are part of the Harvard Medical School Therapeutics Graduate Program working to advance therapeutics discovery, development, and applications to improve the treatment of disease.
  • Launched with six fellows in 2019, the Fujifilm Fellowship has now grown to reach 34 recipients to date, including six alumni.
  • “Fujifilm is proud to support Harvard Medical School as it helps to shape our world’s future scientists.

Fujifilm and Decentralized Pictures Announce the 2024 / 2025 Fujifilm Aspiring Filmmakers Award Series

Retrieved on: 
Monday, February 12, 2024
American Zoetrope, ARV, Francis Ford, DCP, Calendar, Life, Film industry

The 2024 / 2025 Fujifilm Aspiring Filmmakers Award Series of quarterly awards will be hosted on the DCP platform, where DCP’s community of film fans and enthusiasts will have the opportunity to vote to choose filmmakers who will be awarded FUJIFILM digital cameras with lens kit products, as well as production support and mentorship.

Key Points: 
  • The 2024 / 2025 Fujifilm Aspiring Filmmakers Award Series of quarterly awards will be hosted on the DCP platform, where DCP’s community of film fans and enthusiasts will have the opportunity to vote to choose filmmakers who will be awarded FUJIFILM digital cameras with lens kit products, as well as production support and mentorship.
  • Fujifilm Aspiring Filmmakers Award Series, Phase One (2024): U.S.-resident filmmakers will be invited to submit proposals on the DCP platform for three- to five-minute short films based on a creative prompt unique to each quarter in 2024.
  • Fujifilm Aspiring Filmmakers Award Series, Phase Two (2025): In Spring 2025, the 12 Phase One Award projects will be entered into a second creative award on the DCP platform to be rated by the DCP community.
  • “We’re thrilled to launch this award series with a partner that shares our dedication to championing aspiring filmmakers, and excited to see which projects our community chooses to support on the DCP platform.”

Luminar Neo Partners With FUJIFILM North America Corporation to Host 50 Free Photo Walks Nationwide

Retrieved on: 
Monday, February 12, 2024
Lens, Photography, Learning, Nightclub

They’ll also have the chance to interact with Luminar Neo and Fujifilm personnel in person, to gain valuable photography tips and insight.

Key Points: 
  • They’ll also have the chance to interact with Luminar Neo and Fujifilm personnel in person, to gain valuable photography tips and insight.
  • These photo walks are mini-adventures that will bring people together and allow them to see their surroundings in a new light.
  • “At almost every event in which Fujifilm participates, we look for an opportunity to integrate photo walks,” said Victor Ha, vice president, FUJIFILM North America Corporation, Electronic Imaging Division.
  • The first photo walks will take place in Las Vegas, Dallas, and Salt Lake City, starting in March 2024.

Fujifilm’s Synapse® Vendor Neutral Archive (VNA) Earns “Best in KLAS” for Fifth Consecutive Year

Retrieved on: 
Wednesday, February 7, 2024
Cardiology, Mammography, Software, Radiology, DICOM, Enterprise imaging, Feedback, VNA, Research, Enterprise, Informatics, Health, Trust, Synapse, PACS, Human, Medical imaging

Best in KLAS is an industry insights initiative by KLAS Research that recognizes software and services companies that excel in helping healthcare professionals improve patient care.

Key Points: 
  • Best in KLAS is an industry insights initiative by KLAS Research that recognizes software and services companies that excel in helping healthcare professionals improve patient care.
  • “Earning Best in KLAS for VNA for the fifth consecutive year is truly an honor as it underscores our customer’s unwavering trust in our technology and business,” says Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation.
  • The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation,” says Adam Gale, Research CEO, KLAS.
  • This includes DICOM and non-DICOM objects to ensure the full patient imaging picture is available to those who need it.

FUJIFILM Cellular Dynamics and Opsis Therapeutics Announce License with BlueRock Therapeutics for iPSC-derived Cell Therapy Candidate

Retrieved on: 
Tuesday, January 23, 2024
Patient, B cell, Therapy, Cell, IPSC, IRD, Paratriathlon, Partnership, Retina, IND, Human, AMD, Bayer, Peripheral vision, Pharmaceutical industry

an exclusive, worldwide license to develop and commercialize an iPSC-derived cell therapy candidate for the treatment of human retinal diseases.

Key Points: 
  • an exclusive, worldwide license to develop and commercialize an iPSC-derived cell therapy candidate for the treatment of human retinal diseases.
  • BlueRock Therapeutics, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, exercised its option to exclusively license OpCT-001, an iPSC-derived photoreceptor cell therapy for human retinal diseases.
  • Following the option exercise by BlueRock Therapeutics, FUJIFILM Cellular Dynamics and Opsis Therapeutics received an undisclosed license fee and are eligible to receive payments upon achievement of certain development and commercial milestones.
  • OpCT-001 is the first iPSC therapy candidate to be licensed from the strategic research and development alliance that FUJIFILM Cellular Dynamics, Opsis Therapeutics, and BlueRock Therapeutics entered in 2021 to discover and develop off-the-shelf iPSC-derived cell therapies for ocular diseases.